Developments and challenges in hit progression within fragment-based drug discovery.

Area of Science:

• Medicinal Chemistry
• Drug Discovery

Background:

• Fragment-based Drug Discovery (FBDD) is a key strategy for identifying novel therapeutics.
• The Design, Make, Test (DMT) cycle guides the optimization of initial fragment hits.
• Fragment progression, converting hits to leads, presents significant challenges in FBDD.

Purpose of the Study:

• To review the challenges encountered during fragment progression in FBDD.
• To highlight recent advancements aimed at overcoming these fragment progression hurdles.
• To provide insights into improving the efficiency of lead compound development from initial fragments.

Main Methods:

• Literature review of fragment-based drug discovery methodologies.
• Analysis of the Design, Make, Test (DMT) cycle within FBDD.
• Examination of common challenges in fragment-to-lead optimization.

Main Results:

• Fragment progression faces difficulties in improving potency and properties while maintaining chemical tractability.
• Recent developments focus on innovative synthetic strategies and improved screening assays.
• Structure-Activity Relationship (SAR) modeling remains crucial for guiding optimization efforts.

Conclusions:

• Addressing fragment progression challenges is vital for successful FBDD.
• Novel chemical approaches and refined testing strategies are enhancing lead compound generation.
• Continued innovation in FBDD methodologies will accelerate the discovery of new therapeutics.